Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 114,355 | 114,140 | 108,769 | 104,609 | 101,258 |
| Cost of Goods | 18,709 | 17,674 | 17,008 | 15,692 | 15,518 |
| Gross Profit | 95,646 | 96,466 | 91,761 | 88,917 | 85,740 |
| Operating Expenses | 77,309 | 81,642 | 80,230 | 80,183 | 74,500 |
| Operating Income | 19,046 | 15,498 | 11,539 | 9,426 | 11,758 |
| Other Income | -146 | 829 | 1,727 | -102 | 842 |
| Pre-tax Income | 18,900 | 16,327 | 13,266 | 9,324 | 12,600 |
| Income Tax | 206 | 340 | 267 | 414 | 375 |
| Net Income Continuous | 18,694 | 15,987 | 12,999 | 8,910 | 12,225 |
| Net Income | $18,694 | $15,987 | $12,999 | $8,910 | $12,225 |
| EPS Basic Total Ops | 0.50 | 0.43 | 0.35 | 0.26 | 0.34 |
| EPS Basic Continuous Ops | 0.50 | 0.43 | 0.35 | 0.25 | 0.34 |
| EPS Diluted Total Ops | 0.48 | 0.42 | 0.34 | 0.24 | 0.32 |
| EPS Diluted Continuous Ops | 0.48 | 0.42 | 0.34 | 0.24 | 0.32 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.42 | 0.34 | 0.32 | 0.35 |
| EBITDA(a) | $22,405 | $18,601 | $14,951 | $12,747 | $14,882 |